Validation of contemporary stroke and bleeding risk stratification scores in non-anticoagulated Chinese patients with atrial fibrillation
Yutao Guo(Chinese General Hospital College of Nursing and Liberal Arts), Gregory Y.H. Lip(Medical University of Białystok), Yutang Wang(Federation University), Dexian Zhang(Chinese PLA General Hospital), Haijun Wang(Hebei Medical University), Yu Zhang(Chinese PLA General Hospital), Xiaoning Zhao(Chinese PLA General Hospital), Andrew D. Blann(Birmingham City Hospital), Jingling Ma(Chinese PLA General Hospital), Stavros Apostolakis(Birmingham City Hospital)
Cited by 81
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
|European Heart Journal|2016|2.5k
2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed Under the Auspices of the ESC Committee for Practice Guidelines
|European Journal of Heart Failure|2016|1.8k
Antithrombotic Therapy for Atrial Fibrillation
|CHEST Journal|2012|919